These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1354059)

  • 21. Benzodiazepines and neurotic anxiety. Critique.
    Solomon K
    N Y State J Med; 1976 Dec; 76(13):2156-64. PubMed ID: 11427
    [No Abstract]   [Full Text] [Related]  

  • 22. [Arousal and the psychopharmacology of anxiety in experimental models].
    Kaluev AV; Nutsa NA
    Eksp Klin Farmakol; 1998; 61(5):69-74. PubMed ID: 9854641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral and physiological responses to benzodiazepine receptor antagonists.
    Crawley JN; Ninan PT; Pickar D; Chrousos GP; Skolnick P; Paul SM
    Psychopharmacol Bull; 1984; 20(3):403-7. PubMed ID: 6147874
    [No Abstract]   [Full Text] [Related]  

  • 24. Implication of 5-HT2 receptor subtypes in the mechanism of action of the GABAergic compound etifoxine in the four-plate test in Swiss mice.
    Bourin M; Hascoët M
    Behav Brain Res; 2010 Apr; 208(2):352-8. PubMed ID: 20006646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of persistent anxiety and novel uses for anxiolytics.
    J Clin Psychiatry; 1996; 57 Suppl 7():3-95. PubMed ID: 8690695
    [No Abstract]   [Full Text] [Related]  

  • 26. Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link.
    Stahl SM
    J Clin Psychiatry; 1997; 58 Suppl 8():20-6. PubMed ID: 9236732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The neurochemical profile of the dorsal hippocampus and the antiaversive effects of anxiolytics in different models of anxiety in rats].
    Talalaenko AN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1993; 43(3):621-6. PubMed ID: 8103252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do animal models of anxiety predict anxiolytic-like effects of antidepressants?
    Borsini F; Podhorna J; Marazziti D
    Psychopharmacology (Berl); 2002 Sep; 163(2):121-41. PubMed ID: 12202959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astra Award Lecture. The psychopharmacology of 5-HT3 receptors.
    Costall B; Naylor RJ
    Pharmacol Toxicol; 1992 Dec; 71(6):401-15. PubMed ID: 1362267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anxiolytic potential of 5-HT3 receptor antagonists.
    Costall B; Naylor RJ
    Pharmacol Toxicol; 1992 Mar; 70(3):157-62. PubMed ID: 1349746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of typical and atypical anxiolytics on the behavior and electrophysiological parameters of rats with model cerebrovascular pathology].
    Molodavkin GM; Cadikov MK; Voronina TA; Sadikova ZU; Meletova OK; Pchelkina MI; Larentsova LI; Gan'shina TS; Mirzoian RS
    Eksp Klin Farmakol; 2004; 67(6):16-9. PubMed ID: 15707007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antidepressive drugs - in anxiety, anxiolytics - in depression?].
    Drobizhev MY; Fedotova AV; Kikta SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11 Pt 2):74-8. PubMed ID: 24429969
    [No Abstract]   [Full Text] [Related]  

  • 33. The actions of diazepam and serotonergic anxiolytics vary according to the gender and the estrous cycle phase.
    Fernández-Guasti A; Picazo O
    Pharmacol Biochem Behav; 1990 Sep; 37(1):77-81. PubMed ID: 1979876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strain-dependent effects of diazepam and the 5-HT2B/2C receptor antagonist SB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze.
    Takahashi RN; Berton O; Mormède P; Chaouloff F
    Braz J Med Biol Res; 2001 May; 34(5):675-82. PubMed ID: 11323756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
    Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of serotonergic affect control.
    Kennett GA
    Adv Exp Med Biol; 1991; 294():231-43. PubMed ID: 1685293
    [No Abstract]   [Full Text] [Related]  

  • 37. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
    Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
    Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The neurochemical profile of the caudate nucleus in the anxiolytic action of benzodiazepine and nonbenzodiazepine tranquilizers on different models of anxiety].
    Talalaenko AN; Gordienko DV; Markova OP
    Eksp Klin Farmakol; 2000; 63(1):14-8. PubMed ID: 10763103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal models of anxiety: are they suitable for predicting drug action in humans?
    Bourin M
    Pol J Pharmacol; 1997; 49(2-3):79-84. PubMed ID: 9437753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiolytic profiles.
    Gershon S; Eison AS
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):45-57. PubMed ID: 6139369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.